01—Abstract
Summary
Summary of the 8-K filed February 13, 2020. Cited figures are marked; the original filing is the authoritative source.
Moderna, Inc. (MRNA) filed an 8-K on February 13, 2020, primarily to announce the date and key deadlines for its 2020 Annual Meeting of Stockholders.
The meeting is scheduled for April 29, 2020, at the company's Cambridge, Massachusetts office. This announcement is crucial for investors as it sets the timeline for submitting shareholder proposals and director nominations for inclusion in the company's proxy materials. The significant change from the previous year's meeting date (June 27, 2019) means that previously established deadlines are no longer applicable.
Investors seeking to present proposals or nominate directors at the 2020 Annual Meeting must adhere to a strict deadline of February 24, 2020, for their submissions to be considered for inclusion in Moderna's official proxy statement. This early deadline requires proactive engagement from shareholders who wish to influence corporate governance or present specific business matters.
02—Key points
Key Highlights
- Moderna has scheduled its 2020 Annual Meeting of Stockholders for April 29, 2020.
- The meeting will take place at Moderna's corporate offices in Cambridge, Massachusetts.
- The record date for determining eligible stockholders is March 2, 2020.
- A key deadline of February 24, 2020, is established for all shareholder proposals and director nominations to be included in the company's proxy materials.
- This deadline is earlier than the previous year's meeting date would suggest, requiring timely action from shareholders.
- Shareholder proposals must comply with SEC regulations (Rule 14a-8) and Moderna's bylaws.
- Notices of nominations or proposals must be sent to the Corporate Secretary at the company's principal executive offices.
03—Questions
Frequently Asked Questions
When is Moderna's 2020 Annual Meeting of Stockholders?
The 2020 Annual Meeting of Stockholders is scheduled to be held on Wednesday, April 29, 2020.
What is the deadline for submitting shareholder proposals or director nominations for the 2020 Annual Meeting?
The deadline for submitting shareholder proposals or director nominations to be considered for inclusion in Moderna's proxy materials for the 2020 Annual Meeting is Monday, February 24, 2020.
Where should shareholder proposals and nominations be sent?
All shareholder proposals, notices of proposed business, or director nominations should be sent in writing to: Corporate Secretary, Moderna, Inc., 200 Technology Square, Cambridge, Massachusetts 02139.
Why is the deadline for proposals February 24, 2020, and not later?
The deadline is February 24, 2020, because the date of the 2020 Annual Meeting (April 29, 2020) differs by more than thirty days from the anniversary date of the 2019 Annual Meeting (June 27, 2019). This significant shift in timing means that the previously applicable deadlines for proposals are no longer valid, and new, earlier deadlines must be met for inclusion in the proxy materials.
04—Continue